Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 137 companies made new 52-week highs.
The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 12)
77 Biggest Movers From Yesterday
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to engage in cryptocurrency mining.
Analyzing Sesen Bio’s Unusual Options Activity
On Thursday, shares of Sesen Bio (NASDAQ:SESN) saw unusual options activity. After the option alert, the stock price moved up to $4.17.
Sesen Bio Announces Partnership with Eczacibasi Pharmaceuticals Marketing for the Commercialization of Vicineum in Turkey; Sesen Bio To Receive $1.5M Upfront And Is Eligible For Additional Regulatory And Commercial Milestone Payments
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Eczacibasi Pharmaceuticals Marketing (EIP), part of the Eczacibasi Group and one of Turkey’s pioneering pharmaceutical companies with a focus on innova
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdicts.
Sesen Bio, Qilu Pharmaceutical Announce Enrollment Of First Patient In Clinical Trial For Vicineum In China
Sesen Bio (NASDAQ:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and its partner in Greater China, Qilu Pharmaceutical, announced
Analyzing Sesen Bio’s Unusual Options Activity
On Friday, shares of Sesen Bio (NASDAQ:SESN) saw unusual options activity. After the option alert, the stock price moved up to $4.14.